Skip to main content

Advertisement

Log in

Experience in creating new drugs using traditional technologies

  • Search for new drugs
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Working hypotheses for the creation of new potential drugs including Class III antiarrhythmic (nibentan, niferidyl), antiallergic (theoritin), and antituberculosis (hixozid) agents are formulated and experimental data on the activity of the obtained compounds are presented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. R. G. Glushkov, S. P. Golitsyn, E. V. Dorodnikova, et al., Vestn. Ross. Akad. Med. Nauk, No. 11, 38–42 (1998).

  2. R. G. Glushkov, M. D. Mashkovski, and S. D. Yuzhakov, Drugs Future, 22, 30–33 (1997).

    CAS  Google Scholar 

  3. R. G. Glushkov, S. D. Yuzhakov, A. I. L?vov, et al., Khim.-farm. Zh., 45(2), 3–12 (2011).

    Google Scholar 

  4. R. G. Glushkov and A. I. L’vov, RF Pat. No. 2059612, “Method for preparing 1-phenyl-(1-p-nitrobenzoylamino)-5-N,N-diethylaminopentane and 1-phenyl-1-amino-5-N,N-diethylaminopentane hydrochloride”; Byull. Izobret., No. 13 (1996).

  5. M. D. Mashkovski, R. G. Glushkov, S. Ya. Skachilova, et al., SU Pat. No. 1833612, “1-Phenyl-1-(p-nitrobenzoylamino)-5-N-piperidino)- or (N,N-diethylamino)pentane hydrochlorides exhibiting anti-arrhythmic and antifibrillatory activity” (1987).

  6. M. D. Mashkovski, R. G. Glushkov, E. V. Dorodnikova, et al., Khim.-farm. Zh., 29(3), 27–31 (1995).

    Google Scholar 

  7. L. V. Rozenshtraukh and E. P. Anyukhovskii, Kardiologiya, 35(5), 25–36 (1995).

    Google Scholar 

  8. E. B. Maikov, S. A. Bakalov, I. B. Krutanov, et al., Kardiologiya, 36(6), 38–51 (1996).

    Google Scholar 

  9. M. Ya. Ruda, I. N. Merkulova, A. E. Tararak, et al., Kardiologiya, 36(6), 28–37 (1996).

    Google Scholar 

  10. E. B. Maikov, S. A. Bakalov, I. B. Krutanov, et al., Kardiologiya, 35(5), 10–18 (1995).

    Google Scholar 

  11. R. G. Glushkov and S. D. Yuzhakov, Khim.-farm. Zh., 45(1), 3–13 (2011).

    Google Scholar 

  12. R. G. Glushkov and S. D. Yuzhakov, RF Pat. No. 2,333,212, “Derivatives of 1- and 7-[omega-(benzhydryl-4-piperazinyl-1)alkyl]xanthines exhibiting antihistamine and anti-allergic activity”; Byull. Izobret., No. 25 (2008).

  13. M. D. Mashkovskii, Drugs [in Russian], Novaya Volna, Moscow (2005), p. 292.

    Google Scholar 

  14. R. G. Glushkov, M. I. Perel’man, G. B. Sokolova, et al., RF Pat. No. 2209067, “Combined antituberculosis drugs as a composite of quinoxalin-1,4-dioxide derivatives with known antituberculosis drugs”; Byull. Izobret., No. 21 (2003).

  15. R. G. Glushkov, G. B. Sokolova, L. Yu. Krylova, et al., Probl. Tuberk. Bolezn. Legk., No. 3, 20–25 (2007).

  16. R. G. Glushkov and G. B. Sokolova, Antibiot. Khimioter., 53(5–6), 11–13 (2008).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

* S. D. Yuzhakov, deceased.

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 45, No. 9, pp. 3–7, September, 2011.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glushkov, R.G., Yuzhakov*, S.D. Experience in creating new drugs using traditional technologies. Pharm Chem J 45, 517–521 (2011). https://doi.org/10.1007/s11094-011-0670-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-011-0670-3

Keywords

Navigation